Rotavirus (RV) entrapped in polylactide (PLA) and polylactide-coglycolide (PLGA) polymer particles were formulated and evaluated in mice for improved immunogenicity using oral, intranasal (IN), and intramuscular (IM) routes of administration. Microparticles of size ranges between 1 and 8 µm were prepared using double emulsion solvent evaporation technique. Stabilizers like mouse serum albumin, sucrose, and sodium bicarbonate that were used during particle formulation helped in minimizing the denaturation of the entrapped antigen. Immunization with 20 µg of antigen entrapped in polymeric particles through various routes of administration elicited measurable amount of antibody titer in mice. The immunoglobulin A (IgA) and immunoglobulin G (IgG) titer (≥4-fold rise between pre and post immunized sera) was analyzed by the use of enzyme-linked immunosorbent assay. PLGA encapsulated RV microparticles elicited better antibody response through IN route (90%) where as PLA encapsulated RV microparticles showed improved response when administrated through oral route (83.3%). Overall, the performance of IN route based immunization was significantly higher than oral and IM route ( p<0.001) with both the polymers. The results are of indication that, PLGA encapsulated RV microparticles have greater potential for vaccine formulation to combat rotavirus infection.
Parashar, U.D. , Bresse, J.S., Widdowson, M.A. and Gentsch, J.R.New Breath for Rotavirus Vaccines, Drug Discov. Today: Ther. Strat., 2006: 3: 159-165.
2.
Parashar, U.D. , Gibson, C.J., Bresse, J.S. and Glass, R.I.Rotavirus and Severe Childhood Diarrhea , Emerg. Infect. Dis., 2006: 12: 304-306.
3.
Mena, J.A., Ramirez, O.T. and Palomares, L.A.Intracellular Distribution of Rotavirus Structural Proteins and Virus-like Particles Expressed in the Insect Cell-baculovirus System, J. Biotech., 2006: 122: 443-452.
4.
Naghipoura, M., Nakagomia, T. and Nakagomia, O.Issues with Reducing the Rotavirus-associated Mortality by Vaccination in Developing Countries , Vaccine , 2008: 26: 3236-3241.
5.
Franco, M.A. , Angel, J. and Greenberg, H.B.Immunity and Correlates of Protection for Rotavirus Vaccines, Vaccine , 2006: 24: 2718-2731.
6.
Murphy, T.V. , Gargiullo, P.M., Massoudi, M.S. et al. Rotavirus intussusception among infants given an oral rotavirus vaccine, N. Engl. J. Med., 2001: 344: 546-572.
7.
Dennehy, P.H.Rotavirus vaccines - An update, Vaccine, 2007: 25: 3137-3141.
8.
Grimwood, K. and Buttery, J.P.Clinical update: rotavirus gastroenteritis and its prevention, Lancet, 2007: 370: 302-304.
9.
Zomera, T.P. , Van Duynhovena, Y.T.H.P., Mangenb, M.J.J. et al. Assessing the Introduction of Universal Rotavirus Vaccination in the Netherlands, Vaccine, 2008: 26: 3757-3764.
10.
Offit, P.A. , Khoury, C.A., Moser, C.A., et al. Enhancement of Rotavirus Immunogenicity by Microencapsulation , Virology, 1994: 203: 134-143.
11.
Mora, J.R., Bono, M.R., Manjunath, N. et al. Selective Imprinting of Gut - Homing T Cells by Peyer’s Patch Cells, Nature, 2003: 424: 88-93.
12.
McGhee, J.R. ( 1992). Mucosal-associated Lymphoid Tissue (MALT), In: Roitt, I.M. and Delves, P.J. (eds), Encyclopedia of Immunology, San Diego, Academic Press, pp. 1110-1114.
13.
Isaka, M., Yasuda, Y., Kozuka, S. et al. Induction of Systemic and Mucosal Antibody Response in Mice Immunized Intranasally with Aluminium-non-adsorbed Diptheria Toxoid Together with Recombinant Cholera Toxin B Subunit as an Adjuvant, Vaccine, 2000: 18: 743-751.
14.
Barackman, J.D., Ott, G. and Hagan, D.T.O’.Intranasal Immunization of Mice with Influenza Vaccine in Combination with Adjuvant LT - R72 Induces Potent Mucosal and Serum Immunization which is Stronger than that with the Traditional Intramuscular Immunization, Infect. Immun., 1997: 67: 4267-4279.
15.
Cahill, E.S. , O’ Hagan , D.T., Illum, L. and Barnard, A.Immune Responses Against Bordetella Pertussis Infection after Intranasal Immunization of Mice with Filamentous Haemagglutinin in Solution or Incorporated in Biodegradable Microparticles, Vaccine, 1995: 13: 455-462.
16.
Davis, S.S.Nasal Vaccines, Adv. Drug Deliv. Rev., 2001: 51: 21-42.
17.
O’ Hagan, D.T., Jeffery, H., Roberts , M.J., McGhee , J.P. and Davis, S.S.Controlled Release Microparticles for Vaccine Development, Vaccine, 1991: 9: 768-771.
18.
Jiang, W., Gupta, R.K., Despande, M.C. and Schwendeman, S.P.Biodegradable Poly(lactic-co-glycolic acid) Microparticles for Injectable Delivery of Vaccine Antigens, Adv. Drug. Deliv. Rev., 2005: 57: 391-410.
19.
Periwal, S.B. , Speaker, T.J. and Cebra, J.J.Orally Administered Microencapsulated Reovirus can Bypass Suckled, Neutralizing Maternal Antibody that Inhibits Active Immunization of Neonates, J. Virol., 1997: 71: 2844-2850.
20.
Khoury, C.A. , Moser, C.A., Speaker, T.J. and Offit, P.A.Oral Inoculation of Mice with Low Doses of Microencapsulated, Noninfectious Rotavirus Induces Virus-specific Antibodies in Gut-associated Lymphoid Tissue, J. Infect. Dis., 1995: 172: 870-874.
21.
VanCott, J.L. , Prada, A.E., McNeal , M.M. et al. Mice Develop Effective but Delayed Protective Immune Responses when Immunized as Neonates Either Intranasally with Nonliving VP6/LT(R192G) or Orally with Live Rhesus Rotavirus Vaccine Candidates, J. Virol., 2006 : 80: 4949-4961.
22.
McNeal, M.M., Basu, M., Bean , J.A., et al. Identification of an Immuno-dominant CD4+ T Cell Epitope in the VP6 Protein of Rotavirus Following Intranasal Immunization of BALB/c Mice, Virology , 2007: 363: 410-418.
23.
Ray, P. , Malik, J., Singh, R.K. et al. Rotavirus Non-structural Protein NSP4 Includes Heterotypic Antibody Responses during Natural Infection in Children , J. Infect. Dis., 2003: 187: 1786-1793.
24.
Raghuvanshi, R.S., Singh, Om and Panda, A.K.Formulation and Characterization of Immunoreactive Tetanus Toxoid Biodegradable Polymer Particles, Drug Delivery , 2001: 2: 99-106.
25.
Raghuvanshi, R.S., Goyal, S., Singh , Om and Panda, A.K.Stabilization of Dichloromethane-induced Protein Denaturation during Microencapsulation , Pharma Dev. Tech., 1998: 3: 269-276.
26.
Srinivasan, C. , Katare, Y.K., Muthukumaran . T. and Panda, A.K.Effect of Additives on Encapsulation Efficiency, Stability and Bioactivity of Entrapped Lysozyme from Biodegradable Polymer Particles, J. Microencapsul., 2005: 2: 127-138.
27.
Katare,Y.K. , Muthukumaran, T. and Panda, A.K.Influence of Particle Size, Antigen Load, Dose and Additional Adjuvant on the Immune Response from Antigen Loaded PLA Microparticles, Int. J. Pharm., 2005: 301: 149-160.
28.
Kanchan, V. and Panda, A.K.Interactions of Antigen-loaded Polylactide Particles with Macrophages and their Correlation with the Immune Response , Biomaterials, 2007: 35: 5344-5357.
29.
Houchin, M.L. , Neuenswander, S.A. and Topp, E.M.Effect of Excipients on PLGA Film Degradation and the Stability of an Incorporated Peptide, J. Control Rel. , 2007: 117: 413-420.
30.
Chambina, O. , Champion, D., Debraya , C., et al. Effects of Different Cellulose Derivatives on Drug Release Mechanism Studied at a Preformulation Stage, J. Control Rel., 2004: 95: 101-108.
31.
Tunon, A., Borjesson, E., Frenning, G. and Alderborn, G.Drug Release from Reservoir Pellets Compacted with some Excipients of Different Physical Properties, Eur. J. Pharm Sci., 2003 : 20: 469-479.
32.
Dennehy, P.H. , Rodgers, G.C. Jr., Ward, R.L., et al. Comparative Evaluation of Reactogenicity and Immunogenicity of Two Dosages of Oral Tetravalent Rhesus Rotavirus Vaccine , Pediatr. Infect. Dis., 1996: 15: 1012-1018.
33.
Joensuu, J. , Koskenniemi, E., Pang , X.L. and Vesikari, T.Randomised, Doubleblind, Placebo Controlled Trial of Rhesus-human Reassortant Rotavirus Vaccine for Prevention of Severe Rotavirus Gastroenteritis, Lancet, 1997: 350: 1205-1209.
34.
Kim, B. , Bowersock, T., Griebel , P. et al. Mucosal Immune Responses Following Oral Immunization with Rotavirus Antigens Encapsulated in Alginate Microspheres , J. Contr. Rel., 2002: 85: 191-202.
35.
Diaz, A.G., Andujar, P.L., Diaz, J.R. et al. Nasal Immunization of Mice with a Rotavirus DNA Vaccine that Induces Protective Intestinal IgA Antibodies, Vaccine, 2004: 23: 489-498.
36.
Jiang, B., Gentsch, J.R. and Glass, R.I.The Role of Serum Antibodies in the Protection Against Rotavirus Disease: An Overview, Clin. Infectious Dis., 2002: 34: 1351-1361.
37.
Westerman, L.E., McClure, H.M., Jiang, B., Almond, J.W. and Glass, R.I.Serum IgG Mediates Mucosal Immunity Against Rotavirus Infection, Proc. Natl. Acad. Sci. USA, 2005: 102: 7268-7273.
38.
Kapikian, A.J. , Wyatt, R.G. and Levine, M.M.Oral Administration of Human Rotavirus to Volunteers: Induction of Illness and Correlates of Resistance , J. Infect. Dis., 1983: 147: 95-106.
39.
Green, K.Y. and Kapikian, A.J.Identification of VP7 Epitopes Associated with Protection Against Human Rotavirus Illness or Shedding in Volunteers , J. Virol., 1992: 66: 548-553.
40.
Yuan, L., Wen, K., Azevedo, M.S.P., et al. Virus-specific Intestinal IFN-γ Producing T Cell Responses Induced by Human Rotavirus Infection and Vaccines are Correlated with Protection Against Rotavirus Diarrhea in Gnotobiotic Pigs, Vaccine, 2008: 26: 3322-3331.
41.
Azevedo, M.S. , Yuan, I., Jeong , K.I., et al. Viremia and Nasal and Rectal Shedding of Rotavirus in Gnotobiotic Pigs Inoculated with Wa Human Rotavirus, J. Virol., 2005 : 79: 5428-5436.
42.
Johanssona, E. , Istratea, C., Charpiliennee , A. et al. Amount of Maternal Rotavirus-specific Antibodies Influence the Outcome of Rotavirus Vaccination of Newborn Mice with Virus-like Particles, Vaccine, 2008: 26: 778-785.
43.
Ciarlet, A.B. , Ciarlet, M., Crowford , S.E., Conner, M.E. and Estes, M.K.Immunogenecity and Protective Efficacy of Rotavirus 2/6-virus-like Particles Produced by Dual Bacculovirus Expression Vector and Administrated Intramuscularly, Intranasally, or Orally to Mice, Vaccine, 2003: 21: 3885-3900.
44.
Ciarlet, M. and Estes, M.K.Rotavirus and Calicivirus Infections of the Gastrointestinal Tract, Curr. Opin. Gastroenterol. , 2001: 17: 10-16.
45.
Graham, D.Y. , Sackman, J.W. and Estes, M.K.Pathogenesis of Rotavirus-induced Diarrhea: Preliminary Studies in Miniature Swine Piglet , Dig. Dis. Sci. , 1984: 29: 1028-1035.
46.
Davidson, G.P. , Gall, D.G., Petric, M., Butler, D.G. and Hamilton, J.R.Human Rotavirus Entritis Induced in Conventional Piglets: Intestinal Structure and Transport , J. Clin. Investig. , 1977: 60: 1402-1409.
